In states with bans on affirmative action programs, the proportion of students from underrepresented racial and ethnic minority groups in U.S. public medical schools fell by more than one-third by five years after those bans went into effect.
A new Supplement released today in the journal Pediatrics suggests that although we are starting to connect the dots between events and experiences early in life and later adult health challenges, we are not doing nearly enough to intervene in childhood to optimize later health outcomes.
Researchers studying the effect of the monoclonal antibody Leronlimab on long COVID-19 may have found a surprising clue to the baffling syndrome, one that contradicts their initial hypothesis. An abnormally suppressed immune system may be to blame, not a persistently hyperactive one as they had suspected.
A report from the Autism Intervention Research Network on Physical Health (AIR-P), a multi-site collaboration housed within UCLA Health’s Department of Medicine, highlights the intersection of autism, poverty and race/ethnicity and their compounding impact on health and health care.
The rate of overdose deaths among U.S. teenagers nearly doubled in 2020, the first year of the COVID pandemic, and rose another 20% in the first half of 2021 compared with the 10 years before the pandemic, even as drug use remained generally stable during the same period.
For a recent six-year period, the injury rate for riders of electric scooters in one section of Los Angeles was higher than the national rates for riders of motorcycles, bicycles and cars, and pedestrians.
A new study led by researchers at UCLA has shown that a specialized primary care medical home improved the care and treatment of patients with serious mental illness, resulting in better mental health-related quality of life.
A new study led by UCLA Health scientists shows highly creative people’s brains appear to work differently from others', with an atypical approach that makes distant connections more quickly by bypassing the “hubs” seen in non-creative brains.
The National Institute of Mental Health has renewed its support for UCLA’s collaborative Center for HIV Identification, Prevention and Treatment Services, or CHIPTS, with a five-year, $7.5 million grant.
psychedelics may find new, legitimate roles in treatment for anxiety, depression, stress disorders, addiction, and other mental and behavioral health problems. But ensuring they do requires developing rigorous, standardized methods to study and apply the results, according to a new report.
The Dementia Care Study (D-CARE), a nation-wide clinical trial assessing the effectiveness of different approaches to caring for people with Alzheimer’s disease and other dementias, has reached its recruitment goal by enrolling 2,176 persons living with dementia and their caregivers
Researchers say the challenges of treating long COVID are amplified by a critical issue: we do not know what constitutes long COVID or how to formally diagnose it, an issue that is further exacerbated by limited research data of varying quality and consistency.
Researchers at UCLA Health have found that Housing First, a national program to provide housing and support for homeless persons, was effective in helping homeless veterans access housing and remain in their homes five years after it was implemented.
In 2020, the first year of the COVID-19 pandemic, the rate of drug overdose deaths among Black Americans surpassed that of whites for the first time since 1999 — a sharp reversal of the situation a decade earlier, when rates were twice as high for whites as for Blacks.
Analyzing breast-cancer tumors with artificial intelligence has the potential to improve healthcare efficiency and outcomes, but doctors should proceed cautiously, according to a new editorial in JAMA Health Forum co-written by Dr. Joann G. Elmore, a researcher at the UCLA Jonsson Comprehensive Cancer Center.
UCLA Health, in partnership with BioscienceLA and UCLA Biodesign, has launched a new accelerator at the intersection of health equity and technology. Aimed at supporting long-term community health resilience and improvements in the aftermath of the COVID-19 pandemic, the UCLA Health TechQuity Accelerator seeks to bridge clinical excellence and innovation for diverse patient populations.
UCLA researchers presented today the first case of a U.S. woman living with HIV-1 that is in remission after she received a new combination of specialized stem cell transplants for treatment of acute myeloid leukemia (AML). The oral abstract was presented at CROI 2022, the Conference on Retroviruses and Opportunistic Infections.
A survey of almost 60,000 Americans who had in-person or virtual telehealth appointments with a doctor in 2020 found that patients rated their experiences with virtual visits the same or even slightly better than seeing a doctor in person.
An interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using magnetic resonance imaging (MRI) to guide precisely-focused high-dose radiation treatment for prostate cancer reduced side effects associated with the treatment. The findings are being presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium in San Francisco, Calif.
A newly launched UCLA Space Medicine Fellowship, the first of its kind in the U.S., aims to develop the next generation of flight surgeons who will support the health, safety, and well-being of human space flight and planetary expeditions.
A team led by UCLA researchers will receive a multi-million dollar grant to study why some people suffer from a devastating fungal infection called Valley Fever, while others suffer seemingly no impact from the disease.
A new study by UCLA researchers and colleagues demonstrates that the Ebola vaccine known as rVSVΔG-ZEBOV-GP results in a robust and enduring antibody response among vaccinated individuals in areas of the Democratic Republic of Congo (DRC) that are experiencing outbreaks of the disease. Among the more than 600 study participants, 95.6% demonstrated antibody persistence six months after they received the vaccine.
The study is the first published research examining post–Ebola-vaccination antibody response in the DRC, a nation of nearly 90 million. While long-term analyses of the study cohort continue, the findings will help inform health officials’ approach to vaccine use for outbreak control, the researchers said.
Join the UCLA Fielding School of Public for the 47th Lester Breslow Distinguished Lecture. Dr. Roger Detels — distinguished research professor of epidemiology at the UCLA Fielding School of Public Health and infectious diseases at the David Geffen School of Medicine at UCLA — will present opportunities realized that have contributed to advancing our understanding of disease pathogenesis as well as the shaping of public health policy and promoting of future public health leaders, both nationally and internationally. The event will be hosted by Dr. Ron Brookmeyer, dean of the UCLA Fielding School of Public Health.
Investigators from UCLA Jonsson Comprehensive Cancer Center have identified a germline biomarker signature that successfully predicts which patients will suffer serious side effects that occur in up to three in 10 patients on anti-PD1/PDL1 therapy, a promising new approach to treating cancer.
Researchers at the Jane and Terry Semel Institute for Neuroscience and Human Behavior at UCLA and the David Geffen School of Medicine at UCLA have developed a new mouse model of Huntington’s disease, providing new clues to the disease and giving researchers a powerful new tool to test new therapies engaging multiple targets.
Neuroscientists at the David Geffen School of Medicine at UCLA in collaboration with scientists at UC Berkeley have discovered that visual stimulation not only guides the way brain cells connect, but actually influences the types of cells that form in the first place – something that was thought to be genetically programmed.
In ‘Recipe for Survival: What You Can do to Live a Healthier and More Environmentally Friendly Life,’ scheduled for publication in January 2022, UCLA Fielding School professor Dr. Dana Ellis Hunnes provides “recipes” for improving personal and planetary health
In it’s first year, the Fielding School’s UCLA Center for LGBTQ+ Advocacy, Research & Health (C-LARAH) has had impact across a spectrum of applied research and organizational work, focused on increasing equity for an underserved community.
A cost analysis of the controversial new Alzheimer’s disease drug aducanumab shows that ancillary care services account for nearly 20% of total Medicare costs related to the drug, or $6,564 per patient per year.
Some of the most socioeconomically disadvantaged patients — those with Medicaid or Medicare-Medicaid dual eligibility insurance — were far less likely than those with other insurance plans to return to using outpatient services at rates approaching normal, pre-pandemic levels.
Researchers in a multi-institution study led by UCLA Health call for more research as well as customized treatments, education and support to empower women living with Parkinson’s disease to address their unmet medical needs.
Dr. Robert Kim-Farley, UCLA Fielding School of Public Health professor of epidemiology and community health sciences, addresses the issue of how the U.S. has coped with the pandemic
The UCLA Center for SMART Health and Hearst Health, have announced a partnership to offer the Hearst Health Prize awarding data science initiatives that demonstrate a positive impact on health outcomes.
Researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used prostate cancer patients’ DNA to create a model that appears to predict who will have side effects from radiation.
A new study finds that while young and healthy mice show clear differences between daytime and nighttime body temperature rhythms, in older and diseased animals the difference essentially disappeared.
A study in mice led by UCLA researchers shows that removing chemical messengers in the brain that are involved in both wakefulness and addiction may make withdrawal from opioids easier and help prevent relapse.
In a study using mice, a UCLA-led team of researchers have improved upon a method they developed in 2017 that was designed to kill HIV-infected cells. The advance could move scientists a step closer to being able to reduce the amount of virus, or even eliminate it, from infected people.
New UCLA-led research in mice suggests that adding a certain type of tomato concentrate to the diet can reduce the intestinal inflammation that is associated with HIV. Left untreated, intestinal inflammation can accelerate arterial disease, which in turn can lead to heart attack and stroke.
Research led by scientists at the Jonsson Comprehensive Cancer Center (JCCC) at UCLA provides new insights into molecular “crosstalk” in pancreas cancer cells, identifying vulnerabilities that could provide a target for therapeutic drugs already being studied in several cancers.
An estimated 370,000 Californians rely on drinking water that may contain high levels of the chemicals arsenic, nitrate or hexavalent chromium, and contaminated drinking water disproportionately impacts communities of color in the state, according to a new analysis led by researchers at the University of California, Berkeley, and the University of California, Los Angeles.
In ‘Public Health Emergencies: Case Studies, Competencies, and Essential Services of Public Health,’ published this month by Springer Publishing, Dr. Robert Kim-Farley, UCLA Fielding School of Public Health professor of epidemiology and community health sciences, writes that the pandemic offers the public – and public health specialists – ample lessons learned for the next public health crisis.
At a time when public and private agencies and the legal system are grappling with how to best assist people who live at the intersection of homelessness and mental illness during a global pandemic, UCLA researchers have found mental health conservatorships for people with disabling, severe mental illness who are also homeless can result in lengthy psychiatric hospitalizations.
UCLA Jonsson Comprehensive Cancer Center researchers led the development of a melanoma model of drug resistance, enabling them to study structures and dynamics resulting in intrachromosomal and extrachromosomal changes that support resistance in cancer cells.
For those gathering with colleagues, friends, and family this holiday season, Dr. Anne Rimoin — UCLA Fielding School of Public Health professor of epidemiology and the Gordon-Levin Endowed Chair in Infectious Diseases and Public Health — shares tips about how to minimize risk.
Researchers from UCLA Jonsson Comprehensive Cancer Center and UCLA Health will participate in dozens of presentations at the annual meeting of the American Society of Hematology (ASH), held virtually and in person in Atlanta Dec. 11-14. A few of these are highlighted here.
Researchers at UCLA Jonsson Comprehensive Cancer Center led a large international study providing what is believed to be the first evidence (albeit indirect) that a recently approved imaging technique improves risk-stratification and long-term prognostic capabilities for patients with high-risk prostate cancer whose conventional imaging showed only localized disease.
Researchers at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have identified rare, naturally occurring T cells that are capable of targeting a protein found in SARS-CoV-2 and a range of other coronaviruses.
A combination of vaccination and naturally acquired infection appears to boost the production of maximally potent antibodies against the COVID-19 virus, new UCLA research finds.